Subtopic Deep Dive
Botulinum Toxin for Post-Stroke Hemiplegia
Research Guide
What is Botulinum Toxin for Post-Stroke Hemiplegia?
Botulinum toxin treatment for post-stroke hemiplegia uses intramuscular injections to reduce wrist and finger spasticity, improving motor function and gait in stroke survivors.
Clinical trials demonstrate botulinum toxin A injections decrease spasticity in upper limbs after stroke (Brashear et al., 2002, 554 citations). Prospective studies show spasticity develops early, within 6 weeks post-stroke in 24.5% of patients (Wissel et al., 2010, 346 citations). Over 20 papers from 2002-2017 explore injection timing, dosing, and physiotherapy integration for hemiplegic recovery.
Why It Matters
Stroke causes hemiplegia in millions annually, with spasticity limiting daily activities and rehabilitation outcomes. Botulinum toxin injections improve wrist extension and finger function, reducing disability as shown in randomized trials (Brashear et al., 2002). Guidelines recommend it for adult spasticity management (Simpson et al., 2016), enhancing quality of life when combined with therapy (Hatem et al., 2016). Jankovic (2004) details its broad neurological applications, including post-stroke care.
Key Research Challenges
Early Spasticity Detection
Spasticity emerges within 6-16 weeks post-stroke, complicating timely intervention (Wissel et al., 2010). Risk factors like paresis and pain require prospective monitoring across cohorts. Standardized assessments like Barthel Index help predict development.
Optimal Injection Timing
Balancing early intervention with functional recovery remains unclear, as upper motor neuron lesions disrupt reflex balance (Trompetto et al., 2014). Studies track tone from day 6 post-stroke but lack consensus on protocols. Physiotherapy integration affects outcomes variably.
Long-term Functional Gains
Reducing spasticity improves mobility short-term, but sustained motor recovery needs multi-modal rehab (Hatem et al., 2016). Metrics like EQ-5D show quality-of-life benefits, yet pain and paresis persist (Wissel et al., 2010). Repeat injections raise tolerability concerns.
Essential Papers
Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery
Samar M. Hatem, Geoffroy Saussez, Margaux della Faille et al. · 2016 · Frontiers in Human Neuroscience · 882 citations
Stroke is one of the leading causes for disability worldwide. Motor function deficits due to stroke affect the patients' mobility, their limitation in daily life activities, their participation in ...
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Marco Pirazzini, Ornella Rossetto, Roberto Eleopra et al. · 2017 · Pharmacological Reviews · 712 citations
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]
David M. Simpson, Mark Hallett, Eric Ashman et al. · 2016 · Neurology · 574 citations
Blepharospasm: OnabotulinumtoxinA (onaBoNT-A) and incobotulinumtoxinA (incoBoNT-A) are probably effective and should be considered (Level B). AbobotulinumtoxinA (aboBoNT-A) is possibly effective an...
Intramuscular Injection of Botulinum Toxin for the Treatment of Wrist and Finger Spasticity after a Stroke
Allison Brashear, Mark Forrest Gordon, Elie P. Elovic et al. · 2002 · New England Journal of Medicine · 554 citations
Intramuscular injections of botulinum toxin A reduce spasticity of the wrist and finger muscles and associated disability in patients who have had a stroke.
Spasticity after spinal cord injury
Melanie Adams, Audrey L. Hicks · 2005 · Spinal Cord · 507 citations
Post Stroke Pain: Identification, Assessment, and Therapy
Rebecca A. Harrison, Thalia S. Field · 2015 · Cerebrovascular Diseases · 411 citations
<b><i>Background:</i></b> Pain is a common complication after stroke and is associated with the presence of depression, cognitive dysfunction, and impaired quality of life. ...
Botulinum toxin in clinical practice
Joseph Jankovic · 2004 · Journal of Neurology Neurosurgery & Psychiatry · 395 citations
Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for a growing number of clinical applications. This review draws attention to new findings about the mechan...
Reading Guide
Foundational Papers
Start with Brashear et al. (2002, 554 citations) for core RCT evidence on wrist/finger injections; follow Jankovic (2004, 395 citations) for mechanisms and Wissel et al. (2010, 346 citations) for spasticity onset.
Recent Advances
Hatem et al. (2016, 882 citations) reviews upper extremity rehab; Simpson et al. (2016, 574 citations) updates spasticity guidelines.
Core Methods
Intramuscular botulinum toxin A injections (Brashear et al., 2002); tone assessment via stretch reflex exaggeration (Trompetto et al., 2014); cohort tracking with Barthel Index (Wissel et al., 2010).
How PapersFlow Helps You Research Botulinum Toxin for Post-Stroke Hemiplegia
Discover & Search
Research Agent uses searchPapers and citationGraph on 'botulinum toxin stroke spasticity' to map 20+ papers, centering Brashear et al. (2002) with 554 citations and its forward citations like Wissel et al. (2010). exaSearch uncovers guideline updates from Simpson et al. (2016); findSimilarPapers links to Hatem et al. (2016) for rehab techniques.
Analyze & Verify
Analysis Agent applies readPaperContent to extract spasticity metrics from Brashear et al. (2002), then verifyResponse with CoVe checks claims against Wissel et al. (2010). runPythonAnalysis processes Barthel Index data from cohorts via pandas for statistical trends; GRADE grading scores evidence as Level B for upper limb efficacy (Simpson et al., 2016).
Synthesize & Write
Synthesis Agent detects gaps in long-term data post-Wissel et al. (2010), flags contradictions between early detection and rehab timing from Hatem et al. (2016). Writing Agent uses latexEditText for protocols, latexSyncCitations to integrate Jankovic (2004), and latexCompile for reports; exportMermaid diagrams injection-physiotherapy workflows.
Use Cases
"Analyze spasticity reduction stats from botulinum trials in stroke patients."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas on Brashear 2002 metrics) → matplotlib plots of wrist scores vs. placebo.
"Draft a review section on botulinum toxin protocols for hemiplegia."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Brashear 2002, Simpson 2016) → latexCompile → PDF with cited guidelines.
"Find code for modeling post-stroke spasticity progression."
Research Agent → paperExtractUrls (Wissel 2010) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on cohort simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ papers via citationGraph from Brashear et al. (2002), producing GRADE-graded systematic reviews on injection efficacy. DeepScan applies 7-step CoVe to verify spasticity timelines in Wissel et al. (2010) against Trompetto et al. (2014). Theorizer generates hypotheses on optimal timing by synthesizing Hatem et al. (2016) rehab data with toxin pharmacology from Pirazzini et al. (2017).
Frequently Asked Questions
What defines botulinum toxin use in post-stroke hemiplegia?
Intramuscular injections target wrist and finger flexors to reduce spasticity and improve function (Brashear et al., 2002).
What are key methods for assessing spasticity post-stroke?
Prospective trials use muscle tone scales, Barthel Index, and EQ-5D at 6 days, 6 weeks, and 16 weeks (Wissel et al., 2010).
Which papers establish foundational evidence?
Brashear et al. (2002, 554 citations) proves efficacy; Jankovic (2004, 395 citations) covers clinical practice (Brashear et al., 2002; Jankovic, 2004).
What open problems persist?
Optimal timing, long-term gains, and physiotherapy integration lack consensus beyond early detection studies (Wissel et al., 2010; Hatem et al., 2016).
Research Botulinum Toxin and Related Neurological Disorders with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Botulinum Toxin for Post-Stroke Hemiplegia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers